A biochemistry graduate student at Newcastle University has found that plants with a unique ability to inhibit the growth of a virus called coronavirus in the body can act as antiviral drugs.
He is the first to have shown that these medicinal plants could be used as anti-viral drugs in humans.
The study is published in the Journal of Medical Virology.
It was based on a study that found the anti-CVD plant tetrahydrocannabinol (THC) was effective against coronaviruses in rats, and has been widely used to treat patients with severe and life-threatening coronaviral infections.
The drugs are usually used to relieve the pain and suffering of people with severe coronavIRIs such as COPD.
But for some people, the drugs are not as effective as other drugs.
But the drugs can also be used to stop inflammation and other infections, which can cause death.
The researchers found that THC and cannabidiol (CBD), the active components in cannabis, inhibited the growth and development of coronavirosts in rats.
The cannabinoids also blocked the growths of coronoviruses that cause pneumonia and acute lung infections.
Cannabinoids inhibit the replication of coronivirus, the coronavire virus that causes COVID-19, which has been a scourge in many countries, and is currently killing hundreds of thousands of people a year.
The scientists found that these drugs had an effect similar to the antiinflammatory effects of aspirin, which are the basis of anti-inflammatory drugs.
They are also able to stop the growth, development and spread of coronvirus in laboratory animals, they say.
The discovery is a significant step in the field of medicinal cannabis.
The research is being carried out by researchers at Newcastle, the University of Glasgow and the University College London.
The researchers tested the effect of THC and CBD on COVID coronavores in rats with lung inflammation. “
We are excited to have discovered that THC- and CBD-based anti-inflammatories can also act as therapeutics in this regard.”
The researchers tested the effect of THC and CBD on COVID coronavores in rats with lung inflammation.
They found that the compounds inhibited the coronovirus growth in the same way as aspirin did, but by slightly less.
The findings suggest that cannabinoids may be used therapeutically to prevent COVID infections, but are not yet able to treat coronavired diseases in humans, says Professor Crippes.
The new research shows the antiviral properties of cannabinoids, and that these are not limited to COVID.
In a paper published earlier this year, Professor Crolls and his colleagues described how they developed THC-based drugs to treat lung inflammation, but the drugs had to be injected intravenously into patients. “
It looks like there is an effective treatment for COVID in humans.”
In a paper published earlier this year, Professor Crolls and his colleagues described how they developed THC-based drugs to treat lung inflammation, but the drugs had to be injected intravenously into patients.
They said they were now looking at a more potent drug to treat COVID infection.
They described a study using THC-containing pills to treat bronchial asthma.
The pill contained a THC compound called CBD, and was tested on COV-19 coronavore samples.
It showed that the drug significantly reduced the number of coronAVs in lung tissue in mice, but not in human volunteers.
In the same study, the team found that cannabinoids inhibit coronaviriene (COVID-2) infection in mice.
This drug can also prevent coronviruses from entering the bloodstream.
They concluded that COVID is a disease that requires a combination of a number of drugs, which includes drugs for preventing coronavirs growth in their body.
They have now developed a new compound, called THC-1, that is also effective against COVID and COVIDs in mice and rats.
They say this could be a new class of antiinflammatory drug, which could potentially be useful in people with COVID disease, and as a therapeutic for COV infections.
It could be available as a pill, as a spray or by mouth.
The team say the compound has shown promising activity in human trials and is a promising candidate for human use.
They also say that the study showed that THC works in the lungs, not the bloodstream, and therefore is safe for use.
The cannabis compound has a very similar mechanism to THC, which blocks COVID, which is why it could be an effective drug in treating COVID outbreaks.
The Newcastle University study was funded by the UK Medical Research Council and the Medical Research Board of Australia.
The paper is: ‘Threshold inhibitory concentrations of THC-1-cannabinoids in the lung